Milan, Italy

Marialuisa Lavitrano

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marialuisa Lavitrano

Introduction

Marialuisa Lavitrano, based in Milan, Italy, is an accomplished inventor with a notable track record of four patents. Her work particularly focuses on advancing cancer treatment and genetic modification technologies, showcasing her commitment to innovation in the medical field. This article delves into her latest patents, career highlights, and collaborative efforts.

Latest Patents

One of Marialuisa Lavitrano’s most groundbreaking patents is for modulator compounds of drug resistance in epithelial tumor cells. This invention outlines a method for treating patients with epithelial cancer using a combination of a BTK protein inhibitor and various chemotherapeutic agents, such as antimetabolites and alkylating agents. The composition aims to effectively reduce tumor cell growth and enhance the efficacy of chemotherapy by exhibiting a synergistic effect.

Another significant patent is her method for the transfer of episomal vectors into animal cells. This innovative approach involves utilizing sperm-mediated gene transfer (SMGT) technology to introduce DNA sequences into animal sperm cells. This technique holds promise for developing genetically modified individuals, marking a significant advancement in genetic engineering.

Career Highlights

Marialuisa Lavitrano has made substantial contributions to her field, working with esteemed companies such as Bionsil, S.r.l. and Bionsil S.r.l. in Liquidazione. Her innovative spirit has propelled her to the forefront of cancer research and genetic technology, establishing her as a respected figure in the scientific community.

Collaborations

Throughout her career, Marialuisa has collaborated with talented individuals such as Emanuela Grassilli and Kristian Helin. These partnerships have been instrumental in fostering creativity and innovation in her research, leading to the development of impactful solutions in health and biotechnology.

Conclusion

Marialuisa Lavitrano's inventions and collaborative efforts highlight her commitment to advancing medical technologies and provide hope for more effective cancer treatments. As an inventor, her contributions continue to influence the fields of oncology and genetic engineering, solidifying her place among the notable innovators of our time.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…